
Feb Czr 2.5mg Suppository
Marketer
Themis Pharmaceuticals Prop Chemosyn Ltd
Salt Composition
Diazepam (2.5mg)
Overview Feb Czr 2.5mg Suppository
Diazepam 2.5mg rectal suppositories are classified as benzodiazepines, employed to manage intensified seizure frequency in individuals already receiving anti-epileptic therapy. This medication offers short-term seizure control by modulating brain activity, promoting relaxation and seizure relief through neural calming. Administered rectally under medical supervision, dosage and duration must strictly adhere to physician instructions due to its addictive potential. Missed doses should be taken immediately upon recall, completing the prescribed course regardless of symptom improvement. Abrupt cessation is contraindicated without consulting a doctor, potentially causing nausea and anxiety. While generally well-tolerated, minor rectal irritation may occur. Dizziness and drowsiness are possible; avoid activities requiring alertness until the effects are known. Consult a physician before use during pregnancy or breastfeeding. Long-term use may necessitate regular blood and liver function monitoring.
Uses of Feb Czr 2.5mg Suppository
Convulsive disorders
Major Benefits of Feb Czr 2.5mg Suppository:
Discard the suppository's packaging prior to administration. Remain recumbent for approximately fifteen minutes following insertion to prevent premature expulsion.
Common Side effects of Feb Czr 2.5mg Suppository:
- Rectal discomfort
How to use Feb Czr 2.5mg Suppository:
Unwrap the suppository prior to administration. Remain recumbent for approximately fifteen minutes following insertion to prevent premature expulsion.
How Feb Czr 2.5mg Suppository works:
Feb Czr 2.5mg rectal suppositories contain a benzodiazepine, facilitating swift absorption into the bloodstream via the rectum's extensive vascular network. This rapid uptake enhances the effects of GABA, a neurotransmitter, thus reducing aberrant neuronal hyperactivity in the brain and managing seizures.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
Administering a 2.5mg Feb Czr suppository during pregnancy carries established risks to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administration of Feb Czr 2.5mg suppositories while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingNone
No drug interactions identified.
KidneyCAUTION
The use of Feb Czr 2.5mg Suppositories requires careful consideration in individuals with impaired kidney function. A modified dosage of Feb Czr 2.5mg Suppositories might be necessary. Physician consultation is advised. Dosage alteration may be warranted with prolonged administration.
LiverCAUTION
The use of 2.5mg Feb Czr suppositories requires careful consideration in individuals with hepatic impairment. Dosage modification of 2.5mg Feb Czr suppositories may be necessary. Physician consultation is advised.
What if you forget to take Feb Czr 2.5mg Suppository :
Should you forget a dose of your 2.5mg Feb Czr suppository, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Feb Czr 2.5mg Suppository
| Label | Value |
|---|---|
| Chemical Type | Benzodiazepine-related compound |
| Developing Habits | Affirmative. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Actions | Benzodiazepine medications |
